DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low - Here's Why

Key Points

• DENTSPLY SIRONA shares hit a new 52-week low, falling to $8.77 during trading and declining 2.5% amid broader investor concerns.
• Analyst sentiment remains mixed but leans neutral: the stock has a consensus “Hold” rating and a $13.31 average price target, substantially above its recent trading level.
• The company beat quarterly earnings and revenue estimates, but revenue declined 4.1% year over year and it posted a negative net margin of 14.99%; institutional investors own 95.7% of its shares.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Thursday. The stock traded as low as $8.77 and last traded at $8.7250, with a volume of 145462 shares. The stock had previously closed at $8.86.

Analyst Upgrades and Downgrades

A number of brokerages have commented on XRAY. Piper Sandler raised their price objective on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 29th. Weiss Ratings reiterated a "sell (e+)" rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd. Barrington Research set a $15.00 price target on shares of DENTSPLY SIRONA in a report on Monday, August 10th. BMO Capital Markets lowered their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating on the stock in a research report on Thursday, September 17th. Finally, Barclays upped their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an "underweight" rating in a research note on Monday, August 24th. Three research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $13.31.

DENTSPLY SIRONA Trading Down 2.5%

The firm has a market capitalization of $1.72 billion, a price-to-earnings ratio of -3.14, a price-to-earnings-growth ratio of 1.14 and a beta of 0.84. The company has a fifty day moving average price of $11.27 and a 200-day moving average price of $11.28. The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.17. The firm had revenue of $898.00 million for the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The firm's revenue was down 4.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. acquired a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $283,405,000. Southpoint Capital Advisors LP acquired a new position in DENTSPLY SIRONA during the first quarter valued at approximately $116,000,000. Edmond DE Rothschild Holding S.A. bought a new position in shares of DENTSPLY SIRONA in the second quarter valued at approximately $47,780,000. Paradigm Capital Management Inc. NY bought a new position in shares of DENTSPLY SIRONA in the second quarter valued at approximately $39,775,000. Finally, Bank of America Corp DE acquired a new stake in shares of DENTSPLY SIRONA in the second quarter worth $31,001,000. Institutional investors and hedge funds own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.